Sonic Healthcare – FY21 Outlook

Sonic Healthcare FY21 revenue +5% to $7.4bn and EBIT growth of 5%+ supports a forward yield of 3%.

FY21 EBITDA estimates, range from $1.5bn – $1.75bn.

You’re not a member!  Trial today

Buy Sonic within the $30 – $32 price range, as indicated below.

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.